Targeted immunogens

Details for Australian Patent Application No. 2004312548 (hide)

Owner Aventis Pasteur, Inc.

Inventors Gallichan, Scott; Uger, A. Robert; Salha, Danielle

Agent Spruson & Ferguson

Pub. Number AU-A-2004312548

PCT Pub. Number WO2005/066203

Priority 60/533,728 31.12.03 US

Filing date 30 December 2004

Wipo publication date 21 July 2005

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/066203 Priority application(s): WO2005/066203

29 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004312568-Built-in light

2004312547-Protease inhibitors